Improving current immunoglobulin therapy for patients with primary immunodeficiency: quality of life and views on treatment

BACKGROUND: Subcutaneous or intravenous immunoglobulin replacement is the mainstay of treatment for most patients with primary immunodeficiency disease (PID). The purpose of this study was to gain an understanding of how existing PID therapies affect patient lives and to identify desired improvement...

Descripción completa

Detalles Bibliográficos
Autores principales: Espanol, Teresa, Prevot, Johan, Drabwell, Jose, Sondhi, Seema, Olding, Laurence
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2014
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4014377/
https://www.ncbi.nlm.nih.gov/pubmed/24833896
http://dx.doi.org/10.2147/PPA.S60771

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4014377/
https://www.ncbi.nlm.nih.gov/pubmed/24833896
http://dx.doi.org/10.2147/PPA.S60771

Ejemplares similares